Home > PE Ratio > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of BALAXI PHARMACEUTICALS is 61.22.

Share Price ₹37.3Nov 19,2026
Market Cap ₹205.9 Cr
Earnings-TTM₹3.4 CrTTM-Consolidated Results
Price/Earnings61.22xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of BALAXI PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹205.9 Cr] as on Nov 19,2026

(/) Earnings [ ₹3.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 61.22x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 61.22 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS


PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS

- BALAXI PHARMACEUTICALS 's latest p/e ratio is 61.22x.

- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 5.43x.

- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 4.99x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 12.75x.

- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?

Peer Comparison (Trading Industry)Earnings-TTM (Cr)PE RatioMarket Cap
BALAXI PHARMACEUTICALS 3.3661.22205.9
ADANI ENTERPRISES LTD4,888.2074.72365,234.0
PREMIER ENERGIES LTD1,777.1621.3337,904.9
ADITYA INFOTECH LTD593.1883.2349,371.2
AEGIS LOGISTICS LTD1,552.5928.6044,400.0
REDINGTON LTD1,576.9716.7626,427.9
RRP SEMICONDUCTOR LTD-0.75-14,466.8010,850.1
HONASA CONSUMER LTD283.1561.0017,271.6
LLOYDS ENTERPRISES LTD227.9542.909,779.4
MMTC LTD145.0154.067,839.0
CELLO WORLD LTD314.8426.048,198.3

Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -14,466.80x
Max industry PE 83.23x
Median industry PE 42.90x
Average industry PE -1,272.45x



You may also like the below Video Courses